Inflammation markers and risk stratification in patients with acute coronary syndromes: Design of the SIESTA study (Systemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes);Marcadores de inflamación y estratificacin de riesgo en pacientes con síndrome coronario agudo: Diseño del estudio SIESTA (Sytemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes)

Revista Espanola de Cardiologia

Volumn 56, Issue 4, 2003, Pages 389-395

  Kaski, Juan Carlos ^a   Cruz Fernández, José María ^b   Fernández Bergés, Daniel ^b   García Moll, Xavier ^b   Jadraque, Luis Martín ^b   Mostaza, José ^b   García Aranda, Víctor López ^b   González Juanatey, José Ramón ^b   Castro Beiras, Alfonso ^b   Martín Luengo, Cándido ^b   Alonso García, Ángeles ^b   López Bescós, Lorenzo ^b   Marcos Gómez, Gonzalo ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

Acute coronary syndromes; Inflammation markers; Risk stratification; Unstable angina

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; THROMBOPLASTIN; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BIOCHEMISTRY; BLOOD CLOT LYSIS; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; ELECTROCARDIOGRAPHY; EMERGENCY SURGERY; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DOCUMENTATION; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VALIDATION PROCESS; VASCULAR DISEASE;

EID: 0038413994     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045655     Document Type: Article

References (47)

1. American Heart Association 2002. Heart and stroke statistical update. Dallas: American Heart Association, 2001. Disponible en: Publications and Resources. Statistics.
2. Marrugat J, Elosua R, Martí H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005. Rev Esp Cardiol 2002;55:337-46.
3. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable Angina Pectoris. N Engl J Med 2000;342:101-14.
4. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST elevation myocardial infarction. J Am Coll Cardiol 2000;36:970-1062.
5. López de Sá E, López Sendón JL, Anguera I, Bethencourt A, Bosch X. Prognostic value of clinical variables at presentation in patients with non-ST segment elevation acute coronary syndrome. Medicine 2002;81:434-42.
6. Swanson GD, Denson KWE, Wells AJ, Jamrozik K, Colditz GA, Fuster V, et al. Passive smoking and coronary heart disease. N Engl J Med 1999;341:697-700.
7. Fischer A, Gutstein DE, Fuster V. Thrombosis and coagulation abnormalities in the acute coronary syndromes. Cardiol Clin 1999;17:283-94.
8. Forrester JS. Role of plaque rupture in acute coronary syndromes. Am J Cardiol 2000;86:J15-23.
9. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001;88:K10-5.
10. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996;94:2013-20.
11. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336: 1276-82.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
13. Kaski JC. Inflamación, infección y enfermedad coronaria: mitos y realidades. Conferencia especial del XXXV Congreso Nacional de la Sociedad Española de Cardiología. Rev Esp Cardiol 2000; 53:1311-7.
14. Buffon A, Biasucci LM, Liuzzo G, Dónofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12.
15. Zouridakis EG, Schwartzman R, García-Moll X, Cox ID, Fredericks S, Holt DW, et al. Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 2001;22:1578-84.
16. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000;86(Suppl 2):3-8.
17. Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002;300:729-35.
18. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
19. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljundahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
20. Antman EM. Decision making with cardiac troponin tests. N Engl J Med 2002;346:683-93.
21. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
22. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
23. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13.
24. Blankemberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30.
25. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 2000;35:358-62.
26. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
27. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63.
28. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
29. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139-47.
30. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997;96: 4204-10.
31. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002;89:145-9.
32. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina Refractory to standard treatment trial. J Am Coll Cardiol 2000;35: 1535-42.
33. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998;82:715-9.
34. Kaski JC, García-Moll X. C-reactive protein as a clinical marker of risk. Circulation 2000;102:63-4.
35. Koenig W. C-reactive protein and cardiovascular risk: has the time come for screening the general population? Clin Chem 2001;47:9-10.
36. Perez Fernández R, Kaski J. Interleukin-10 and coronary disease. Rev Esp Cardiol 2002;55:738-50.
37. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary sindromes. N Engl J Med 2001;345:1014-21.
38. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1057-59.
39. Marrugat J, Senti M. Why mortality from heart disease is low in France. High cholesterol may not have same effect on cardiovascular risk in southern Europe as elsewhere. BMJ 2000;320:250.
40. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence, REGICOR Investigators. J Epidemiol Community Health 1998;52:707-15.
41. Perez G, Pena A, Sala J, Roset P, Masia R, Marrugat J. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Girona, Spain, 1990-1992. REGICOR Investigators. Int J Epidemiol 1998;27:599-604.
42. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
43. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE), Lancet 2002;359:373-7.
44. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol 2001;4:109-14.
45. López-Bescós L, Aros Borau F, Lidón CR, Cequier FA, Bueno H, Alonso JJ, et al. Actualización de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST. Rev Esp Cardiol 2002;55:631-42.
46. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. ACC key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-30.
47. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction 2002; summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of patients with unstable angina). Circulation 2002:106:1893-900.